Products for Research Use Only
RegisterLogin

Cefixime

CAT: 0804-HY-B1381-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-B1381-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Cefixime (FR-17027) is an orally active antibiotic and a third generation cephalosporin antibiotic, useful for the treatment of a number of bacterial infections[1][2].
CAS Number
79350-37-1
Product Name Alternative
FR-17027; FK-027; CL-284635
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Antibiotic; Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection; Cancer
Assay Protocol
https://www.medchemexpress.com/Cefixime.html
Concentration
10mM
Purity
99.94
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=C(C=C)CS[C@]([H])([C@@H]2NC(/C(C3=CSC(N)=N3)=N\OCC(O)=O)=O)N1C2=O)O
Molecular Formula
C16H15N5O7S2
Molecular Weight
453.45
Precautions
H302, H315, H319, H335
References & Citations
[1]Neu HC, et al. In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefixime. Pediatr Infect Dis J. 1987 Oct;6 (10) :958-62.|[2]Unemo M, et al. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother. 2012 Mar;56 (3) :1273-80.|[3]Matsumoto Y, et al. Antibacterial activity of cefixime against Salmonella typhi and applicability of Etest. J Infect Chemother. 1999 Sep;5 (3) :176-179. |[4]Connolly KL, et al. Pharmacokinetic Data Are Predictive of In Vivo Efficacy for Cefixime and Ceftriaxone against Susceptible and Resistant Neisseria gonorrhoeae Strains in the Gonorrhea Mouse Model. Antimicrob Agents Chemother. 2019 Feb 26;63 (3) :e01644-18.|[5]Shi Y, et al. Restoration of cefixime-induced gut microbiota changes by Lactobacillus cocktails and fructooligosaccharides in a mouse model. Microbiol Res. 2017 Jul;200:14-24.|[6]Stone JW, et al. Cefixime, in-vitro activity, pharmacokinetics and tissue penetration. J Antimicrob Chemother. 1989 Feb;23 (2) :221-8.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
β-lactam

Related Products

CatalogName
HY-B0692-01Cefepime
HY-B0692R-01Cefepime (Standard)
HY-B0692ACefepime (chloride)
HY-108877Cefepime (hydrochloride)
HY-B0616-01Cefepime (Dihydrochloride Monohydrate)
HY-143831SCefepime-d8 (sulfate)
HY-W654100Cefepime-d3 (sulfate)
HY-B0616R-01Cefepime (Dihydrochloride Monohydrate) (Standard)

Alternative Products

CatalogName
EDA35037Cefixime

Popular Products